The early rad catches the tumor?

Journal of Clinical Oncology

Volumn 20, Issue 14, 2002, Pages 3045-3047

  Machtay, Mitchell ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; EDITORIAL; ESOPHAGUS INJURY; HUMAN; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037099682     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.14.3045     Document Type: Editorial

References (10)

1. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104
2. The importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer: The NCIC Clinical Trials Group
3. Initial versus delayed accelerated hyperractionated radiation therapy and concurrent chemotherapy in limited small cell lung cancer: A randomized study
4. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
5. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group
6. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer: Aarhus Lung Cancer Group
7. Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide
8. FDG-PET imaging for the staging and follow-up of small cell lung cancer
9. The incidence of second primary tumors in long-term survivors of small-cell lung cancer
10. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer